Article Text

PDF
AB0482 Evaluation of Current and at The Onset Clinical Manifestations in Systemic Lupus Erythematosus Patients
  1. M. Fernández Matilla1,
  2. E. Grau García2,
  3. G. Poveda Marín2,
  4. C. Feced Olmos2,
  5. E. Labrador Sánchez2,
  6. F.M. Ortiz Sanjuan2,
  7. D. Hervás Marín3,
  8. N. Fernández-Llanio4,
  9. V. Fornes Ferrer3,
  10. K. Arévalo Ruales2,
  11. R. Negueroles Albuixech2,
  12. J. Ivorra Cortés2,
  13. J. Fragio Gil2,
  14. I. Martínez Cordellat2,
  15. J. Valero Sanz2,
  16. I. Chalmeta Verdejo2,
  17. L. González Puig2,
  18. C. Alcañiz Escandell2,
  19. C. Nájera Herranz2,
  20. J. Castellano Cuesta4,
  21. J. Román Ivorra2
  1. 1Rheumatology Research Group, IIS la Fe
  2. 2Rheumatology Department, HUP la Fe
  3. 3Biostatistics Unit, IIS la Fe
  4. 4Rheumatology Department, Hospital Arnau de Vilanova, Valencia, Spain

Abstract

Background Systemic Lupus Erythematosus (SLE) in a multisystemic autoimmune disease that specially affects young women during the second and third decade, and is able to injure different organs and or systems, being the most common one affected the musculoskeletal system.

Objectives To analyse the influence of the time of evolution and age of the patient in the current clinical manifestations and the debut of the disease in patients with SLE.

Methods Cross-sectional prospective study of SLE patients according to the SLICC-2012 criteria, coming from the Rheumatology Service of Arnau de Vilanova Hospital and La Fe Hospital. All patients had a complete blood-test with autoimmunity markers, and clinical, biometrics and treatment data were also collected from the personal interview and the medical history. Biostatistical analysis was performed using the R software version 3.2.3., using a simple, binomial and logistic lineal regression.

Results A total of 140 patients were evaluated; of them, (95% were women) with 33.39±13.63 year-old average at the diagnosis time with a 10.05±11.42 year-evolution of SLE. We can find the clinical manifestations at the onset disease on the table.

We observe statistically significant differences in the musculoskeletal system involvement (P=0.008), and in the presence of vasculitis (P=0.01) in patients with a shorter time of disease evolution. There is also a direct relationship between cardiovascular (P=0.002) and renal (P=0.03) affection in younger patients. Finally, cytopenias are correlated both in young patients (P=0.0009) as well as with a shorter time of evolution (P=0.02).

Conclusions We observe a concordance between our SLE series and those already described at the literature, where renal involvement occurs at younger ages, and the musculoskeletal system involvement occurs early in disease or even as the onset symptom.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.